Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Roma La Sapienza
Age
40–85
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patient of age between 40 to 85
Patient with organ-confined Pca (cT1c and cT2a, N0, M0), diagnosed with TRUS biopsy (min:12 cores)
Patient with PSA ≤ 10 ng/mL
Gleason score 6 (3+3) or max 7 (3+4)
Up to two (2) MR identifiable lesions
No definite evidence of extracapsular extension
You may not be if
Patient under medications that can affect PSA for the last 3 months prior to MRgFUS treatment (Androgen Deprivation Treatment; alpha reductase inhibitors)
Any rectal pathology, anomaly or previous treatment
Identified calcification of 2 mm or more in largest diameter neighboring the rectal wall
Bladder cancer
Seminal vesicle/lymph node
Prostate with multiple cystic lesions
Clareo Health | MR-guided Focused Ultrasound Treatment of Prostate Cancer: Focal Therapy for Locally Non-Advanced Disease
